Sutro Biopharma, Inc 10-Q for FY2023 Q2
Sutro Biopharma, Inc. (STRO)
10-Q
2023-08-10
For: 2023-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on August 10, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10.41M
- down 62.9% from $28.1M a year earlier
- Net loss
- $38.52M
- compared with a net loss of $26.01M a year earlier
- Diluted EPS
- -$0.64
- compared with -$0.55 a year earlier